BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+4.36%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$7.24B
AUM Growth
+$7.24B
(+2.4%)
Cap. Flow
+$197M
Cap. Flow
% of AUM
2.72%
Top 10 Holdings %
Top 10 Hldgs %
34.84%
Holding
226
New
18
Increased
74
Reduced
41
Closed
9
Top Buys
| 1 |
Relay Therapeutics
RLAY
|
$55.4M |
| 2 |
Exact Sciences
EXAS
|
$31M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$22.1M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$20.8M |
| 5 |
MTEM
Molecular Templates, Inc.
MTEM
|
$16.9M |
Top Sells
| 1 |
Pacific Biosciences
PACB
|
$44M |
| 2 |
Halozyme
HALO
|
$33.2M |
| 3 |
Evolent Health
EVH
|
$21.8M |
| 4 |
AKCA
Akcea Therapeutics, Inc. Common Stock
AKCA
|
$20.4M |
| 5 |
Medtronic
MDT
|
$15.2M |
Sector Composition
| 1 | Healthcare | 95.98% |
| 2 | Industrials | 0.6% |
| 3 | Technology | 0.53% |
| 4 | Communication Services | 0.41% |
| 5 | Financials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Charles River Laboratories
CRL
$8.04B
| $79.5M | 1.1% |
351,083
-14,750
| -4% | -$3.34M |
|
27
CRISPR Therapeutics
CRSP
$4.71B
| $79.4M | 1.1% |
949,262
+148,800
| +19% | +$12.4M |
|
28
Exelixis
EXEL
$10.1B
| $75.1M | 1.04% |
3,073,500
+26,000
| +0.9% | +$636K |
|
29
Boston Scientific
BSX
$156B
| $72.1M | 1% |
1,886,297
+155,677
| +9% | +$5.95M |
|
|
MYOV
30
DELISTED
Myovant Sciences Ltd.
MYOV
| $71.5M | 0.99% |
5,092,000
+445,000
| +10% | +$6.25M |
|
31
Stryker
SYK
$150B
| $67.3M | 0.93% |
322,771
-1,171
| -0.4% | -$244K |
|
32
Edwards Lifesciences
EW
$47.8B
| $66.1M | 0.91% |
827,818
+36,136
| +5% | +$2.88M |
|
33
Insulet
PODD
$23.9B
| $63.9M | 0.88% |
269,875
+38,126
| +16% | +$9.02M |
|
34
Becton Dickinson
BDX
$55.3B
| $60.7M | 0.84% |
260,846
+14,906
| +6% | +$3.47M |
|
35
Centene
CNC
$14.3B
| $60.3M | 0.83% |
1,033,647
-9,100
| -0.9% | -$531K |
|
36
Nektar Therapeutics
NKTR
$568M
| $60.3M | 0.83% |
3,632,358
+97,345
| +3% | +$1.61M |
|
37
Generation Bio
GBIO
$40.4M
| $58.1M | 0.8% |
1,880,000
+440,000
| +31% | +$13.6M |
|
38
Cigna
CI
$80.3B
| $56.9M | 0.79% |
335,737
-989
| -0.3% | -$168K |
|
|
39
Relay Therapeutics
RLAY
$619M
| $55.4M | 0.77% |
+1,300,000
| New | +$55.4M |
|
|
MTEM
40
DELISTED
Molecular Templates, Inc.
MTEM
| $54.8M | 0.76% |
5,021,996
+1,544,756
| +44% | +$16.9M |
|
|
GWPH
41
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $54.8M | 0.76% |
562,943
+213,377
| +61% | +$20.8M |
|
42
Jazz Pharmaceuticals
JAZZ
$7.75B
| $50.8M | 0.7% |
356,350
+65,214
| +22% | +$9.3M |
|
43
Scholar Rock
SRRK
$3.14B
| $50.3M | 0.69% |
2,842,515
+96,409
| +4% | +$1.71M |
|
44
DexCom
DXCM
$29.5B
| $50.2M | 0.69% |
121,705
+19,000
| +18% | +$7.83M |
|
|
HRC
45
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $47.7M | 0.66% |
571,069
+149,775
| +36% | +$12.5M |
|
46
Hologic
HOLX
$14.9B
| $46.3M | 0.64% |
696,980
+165,891
| +31% | +$11M |
|
47
Amgen
AMGN
$155B
| $45.7M | 0.63% |
179,613
+11,650
| +7% | +$2.96M |
|
48
HCA Healthcare
HCA
$94.5B
| $43M | 0.59% |
345,085
+1,919
| +0.6% | +$239K |
|
49
Black Diamond Therapeutics
BDTX
$157M
| $42.4M | 0.59% |
1,403,000
| – | – |
|
50
CareDx
CDNA
$727M
| $42.3M | 0.59% |
1,115,903
-50,936
| -4% | -$1.93M |
|